Measles vaccine - Bavarian Nordic

Drug Profile

Measles vaccine - Bavarian Nordic

Alternative Names: Measles vaccine MVA mBN85B - Bavarian Nordic; MVA-BN Measles; MVA-mBN85B

Latest Information Update: 21 Aug 2012

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Bavarian Nordic
  • Class Measles vaccines; Viral vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Discontinued Measles

Most Recent Events

  • 31 Aug 2010 Bavarian Nordic completes a phase II trial in Measles in South Africa (NCT00891007)
  • 31 Mar 2010 Bavarian Nordic completes enrolment in its phase II trial for Measles in South Africa
  • 29 Apr 2008 Immunogenicity data from a phase I trial in healthy volunteers and a preclinical trial in Measles released by Bavarian Nordic
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top